This site is intended for US healthcare professionals

Prescribing Information | Important Safety Information

THE FIRST AND ONLY MUSCLE-TARGETED TREATMENT FOR SMA

FOR SMA1

EXPLORE THE DATA

Motor neuron

ISEMBYLD is indicated for the treatment of spinal muscular atrophy (SMA) in adults and pediatric patients 2 years of age and older who are currently receiving a survival motor neuron 2 (SMN2)-targeted treatment.

MOA


Efficacy


Safety